Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions

2018 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions​
Grüter, T.; Metz, I.; Gahlen, A.; Kneiphof, J.; Stork, L.; Brück, W. & Gold, R. et al.​ (2018) 
Clinical and Experimental Neuroimmunology9(3) pp. 169​-172​.​ DOI: https://doi.org/10.1111/cen3.12466 

Documents & Media

License

Usage license

Details

Authors
Grüter, Thomas; Metz, Imke; Gahlen, Anna; Kneiphof, Janina; Stork, Lidia; Brück, Wolfgang; Gold, Ralf; Kleiter, Ingo
Abstract
Abstract Background Brain biopsies of multiple sclerosis patients identified three intraindividually stable lesion patterns. Apart from beneficial effects of plasma exchange in patients with type II lesions, little is known about how multiple sclerosis lesion histology could guide therapeutic decisions. Case presentation Here, we report on a 53‐year‐old male patient with polysymptomatic cerebral syndrome as the first episode of multiple sclerosis. Brain biopsy showed an inflammatory demyelinating lesion with apoptotic oligodendrocytes and a loss of myelin‐associated glycoprotein, pathological features typical for pattern III lesions. High‐dose steroids and immunosuppressive treatment with mitoxantrone led to a substantial improvement of disability and long‐term clinical stability. Conclusion Mitoxantrone therapy along with steroid pulses could potentially be considered as a therapeutic option for pattern III lesions.
Issue Date
2018
Journal
Clinical and Experimental Neuroimmunology 
ISSN
1759-1961
eISSN
1759-1961
Language
English

Reference

Citations


Social Media